Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia
Authors:
- Amira Abdel Moneam AdlyAAAmira Abdel Moneam Adly
- Iman Ahmed RagabIRIman Ahmed Ragab
- Eman Abdel Rahman IsmailEIEman Abdel Rahman Ismail
- Mona Mohammed FarahatMFMona Mohammed Farahat
- 3 October 2014
- journal article
- Published by Taylor & Francis in Platelets
- Vol. 26 (7) , 645-650
Abstract
Rapid assessment of platelet production would distinguish between thrombocytopenia due to decreased platelet production or increased peripheral platelet destruction. We evaluated the value of immature platelet fraction (IPF) in differentiating immune thrombocytopenia (ITP) from thrombocytopenia secondary to bone marrow failure and its potential use as a prognostic marker. Forty-one young patients with ITP were compared with 14 patients with hematological malignancies under chemotherapy, representing a control group with thrombocytopenia due to bone marrow suppression and 30 age- and sex-matched healthy controls. Patients were studied stressing on bleeding manifestations, organomegaly/lymphadenopathy and therapy. Complete blood count including IPF was performed using Sysmex XE-2100. ITP patients were classified into two subgroups: acute ITP with spontaneous resolution within 3 months from diagnosis and chronic ITP that lasted ≥1 year from diagnosis. Median IPF was 11.8% in patients with ITP, 7% in those with hematological malignancy and 3% in the control group (p < 0.001). ITP patients had significantly higher mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR) and IPF compared with patients with malignancy or healthy controls, while plateletcrit (PCT) was significantly lower in ITP patients than other groups (p < 0.001). IPF was increased in patients with chronic ITP compared with acute ITP group (p < 0.001). Patients with active ITP had the highest IPF followed by those in partial remission, while ITP patients in remission had the lowest IPF. IPF was positively correlated to the number of lines of treatment used, MPV, PDW and P-LCR, while negatively correlated to platelet count and PCT among ITP patients (p < 0.001). Multiple regression analysis showed that platelet count and P-LCR were independently related to IPF. ROC curve analysis revealed that the cut-off value of IPF at 9.4% could be diagnostic for ITP patients with a sensitivity of 88% and a specificity of 85.7%. We suggest that IPF may be a rapid and inexpensive automated marker for etiology of thrombocytopenia and can be integrated as a standard parameter to evaluate the thrombopoietic state of the bone marrow. It may be considered as a potential prognostic marker for the development of chronic ITP.Keywords
This publication has 28 references indexed in Scilit:
- Application of reticulated platelets to transfusion management during autologous stem cell transplantationOncoTargets and Therapy, 2012
- Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopeniaBlood, 2011
- The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantationInternational Journal of Laboratory Hematology, 2010
- ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJournal of Thrombosis and Haemostasis, 2010
- High platelet turnover and reactivity in renal transplant recipients patientsThrombosis and Haemostasis, 2010
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITPBritish Journal of Haematology, 2007
- Immature Platelet Fraction as a Predictor of Platelet Recovery Following Hematopoietic Progenitor Cell TransplantationLaboratory Hematology, 2006
- Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantationTransfusion Medicine, 2006
- A Clinical Evaluation of High Fluorescent Platelet Fraction Percentage in ThrombocytopeniaAmerican Journal of Clinical Pathology, 2006